Orlinger Klaus 4
4 · HOOKIPA Pharma Inc. · Filed Apr 21, 2021
Insider Transaction Report
Form 4
Orlinger Klaus
Sr. VP, Research
Transactions
- Award
Stock Option (Right to Buy)
2021-04-19+26,050→ 26,050 totalExercise: $12.00Exp: 2031-04-19→ Common Stock (26,050 underlying)
Footnotes (1)
- [F1]25% of this option shall vest on April 19, 2022, with the remainder vesting in 12 equal quarterly installments thereafter.